You are leaving Lundbeck.com/slo

You have chosen to visit another
Lundbeck website or a third-party website, which is provided as a service to you. Lundbeck does not control content on third-party websites and cannot make representations concerning the accuracy of information on every website you visit. Lundbeck is not responsible for the privacy policy of any third-party website. We encourage you to read the privacy policy of every website you visit.

Click here to proceed to

Cancel

Lundbeck načrtuje prenos svojih komercialnih dejavnosti v Sloveniji pod upravljanje skupine Swixx Group z dnem 1. december 2025.

 

Za več informacij si oglejte sporočilo za javnost podjetja Lundbeck.

Ruled, but not ruined, by migraine

Audrey Craven knows the isolation migraine can cause. When her migraines were at their worst, Audrey Craven vowed to use her experience to help others navigate their migraine journey and feel less alone.

Read Story

To je Lundbeck

Smo eno redkih podjetij, ki se osredotoča izključno na možganska obolenja, kar je naša posebnost in hkrati tisto, kar nas dela
drugačne.

O nas



Z več kot 70 - letnimi izkušnjami s področja nevroznanosti je Lundbeck razvil ter pripeljal na trg nekatere v svetu najpogosteje predpisane terapije za zdravljenje možganskih obolenj.


Naša znanost

a better life for people with brain diseases

At Lundbeck, we see patients as people and are committed to support the person behind the disease. 

Patients

Partnering

The complexity of brain diseases requires a concerted effort. We are committed to develop new and better treatment options from innovations born in house or externally.

Read More
jason F. houston on working at Lundbeck

Advocacy Makes the Difference

Read More
See All Stories

Try to treat Parkinson's like an old friend

Read Story

Lundbeck na kratko

100

Naši izdelki so registrirani v več kot 100 državah po vsem svetu.

5,600

Po vsem svetu imamo približno 5.600 zaposlenih.

1915

Lundbeck je pred več kot 100 leti ustanovil Hans Lundbeck v Kopenhagnu.